Paul R. Johnston
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Paul R. Johnston has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
- Jens Rolff
Evolutionary Biology, Institute for Biology, Freie Universität Berlin, Berlin, Germany
17 shared publications - Alexandro Rodríguez-Rojas
Clinical Department for Small Animals and Horses, Division of Small Animal Internal Medicine, University of Veterinary Medicine, 1210 Vienna, Austria
9 shared publications - Olga Makarova
Centre for Veterinary Public Health and One Health, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria
5 shared publications - Adam J. Dobson
School of Molecular Biosciences, College of Medical Veterinary and Life Sciences, University of Glasgow
4 shared publications - Dino Peter McMahon
Department for Materials and the Environment, BAM Federal Institute for Materials Research and Testing, 12205, Berlin, Germany
4 shared publications Jens Rolff
Evolutionary Biology, Institute of Biology, Freie Universität Berlin, Berlin, Germany
4 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 15 (10)
Draft genome sequences of non-endemic Mycobacterium tuberculosis Indo-Oceanic and West African lineages recovered in Panama
We report the draft genome sequences of three Mycobacterium tuberculosis isolates recovered from Panamanian residents belonging to the Indo-Oceanic (Lineage 1) and West African (Lineage 5) lineages. These isolates exhibit various drug-resistance profiles, including rifampicin-resistant and multidrug-resistant phenotypes. This highlights the changing molecular epidemiology of tuberculosis in Central America.
- 8 October 2026
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 15 (10)
Open AccessDraft genome sequences of non-endemic Mycobacterium tuberculosis Indo-Oceanic and West African lineages recovered in Panama
We report the draft genome sequences of three Mycobacterium tuberculosis isolates recovered from Panamanian residents belonging to the Indo-Oceanic (Lineage 1) and West African (Lineage 5) lineages. These isolates exhibit various drug-resistance profiles, including rifampicin-resistant and multidrug-resistant phenotypes. This highlights the changing molecular epidemiology of tuberculosis in Central America.
- Open Access
- 9 June 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (6) , 001724
Clinical Rel mutations that increase basal (p)ppGpp promote conjugal transfer of staphylococcal resistance plasmids
Conjugative transfer of plasmids represents a major route through which antibiotic resistance genes are spread. In the case of the prevalent and deadly pathogen Staphylococcus aureus , more than 90% of clinical isolates carry at least one plasmid. While plasmid-encoded mechanisms [e.g. plasmid copy number (PCN)] can influence conjugation frequency, host factors and environmental stimuli can also affect transmission. In particular, stress responses like the stringent response have been associated with increased movement of mobile genetic elements. We have previously shown that clinical mutations in the stringent response controller, Rel, lead to elevated levels of the alarmones guanosine tetra- and pentaphosphate [(p)ppGpp] and antibiotic tolerance in S. aureus . Here, we report that elevated (p)ppGpp in these strains promotes the conjugal transfer of diverse staphylococcal resistance plasmids. We observed that clinical Rel mutations promote donation, but not receipt, of plasmids from the three families of staphylococcal plasmid and a mobilizable plasmid. This increased conjugation frequency could also be induced by chemical induction of the stringent response by mupirocin. Intriguingly, detailed experimental analysis revealed that the effect of elevated (p)ppGpp on plasmid donation was not due to CodY derepression, SOS response induction or increased PCN. Furthermore, comparative transcriptomics of wild-type and mutant donor did not highlight any putative plasmid- or host-derived mechanisms to explain this observation. Further investigations are required to explore the mechanistic link between (p)ppGpp and conjugation, given the pervasive transcriptional and post-translational effects of (p)ppGpp. Overall, the association between Rel mutation and increased plasmid donation is alarming, especially as Rel mutations are being increasingly identified among clinical isolates.
- 9 June 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (6) , 001724
Open AccessClinical Rel mutations that increase basal (p)ppGpp promote conjugal transfer of staphylococcal resistance plasmids
Conjugative transfer of plasmids represents a major route through which antibiotic resistance genes are spread. In the case of the prevalent and deadly pathogen Staphylococcus aureus , more than 90% of clinical isolates carry at least one plasmid. While plasmid-encoded mechanisms [e.g. plasmid copy number (PCN)] can influence conjugation frequency, host factors and environmental stimuli can also affect transmission. In particular, stress responses like the stringent response have been associated with increased movement of mobile genetic elements. We have previously shown that clinical mutations in the stringent response controller, Rel, lead to elevated levels of the alarmones guanosine tetra- and pentaphosphate [(p)ppGpp] and antibiotic tolerance in S. aureus . Here, we report that elevated (p)ppGpp in these strains promotes the conjugal transfer of diverse staphylococcal resistance plasmids. We observed that clinical Rel mutations promote donation, but not receipt, of plasmids from the three families of staphylococcal plasmid and a mobilizable plasmid. This increased conjugation frequency could also be induced by chemical induction of the stringent response by mupirocin. Intriguingly, detailed experimental analysis revealed that the effect of elevated (p)ppGpp on plasmid donation was not due to CodY derepression, SOS response induction or increased PCN. Furthermore, comparative transcriptomics of wild-type and mutant donor did not highlight any putative plasmid- or host-derived mechanisms to explain this observation. Further investigations are required to explore the mechanistic link between (p)ppGpp and conjugation, given the pervasive transcriptional and post-translational effects of (p)ppGpp. Overall, the association between Rel mutation and increased plasmid donation is alarming, especially as Rel mutations are being increasingly identified among clinical isolates.
- Open Access
- 1 January 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (1)
Draft genome sequence of a non-tuberculous Mycobacterium strain isolated from a clinical urine sample
Here, we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory, Royal Infirmary of Edinburgh, UK. The reported genome has a length of 6,749,454 bp, a G+C content of 67.2 mol% and 6,336 protein CDSs. Average nucleotide identity (ANI) analysis identified Mycobacterium vanbaalenii PYR-1 as the closest relative (83.32% ANI), indicating that this isolate likely represents a novel species within the genus. Notably, phenotypic characterization revealed a distinct antimicrobial resistance (AMR) profile. This assembly provides a valuable resource for studying the evolution of AMR mechanisms in nontuberculous mycobacteria and offers insight into resistance phenotypes observed in clinical isolates.
- 1 January 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (1)
Open AccessDraft genome sequence of a non-tuberculous Mycobacterium strain isolated from a clinical urine sample
Here, we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory, Royal Infirmary of Edinburgh, UK. The reported genome has a length of 6,749,454 bp, a G+C content of 67.2 mol% and 6,336 protein CDSs. Average nucleotide identity (ANI) analysis identified Mycobacterium vanbaalenii PYR-1 as the closest relative (83.32% ANI), indicating that this isolate likely represents a novel species within the genus. Notably, phenotypic characterization revealed a distinct antimicrobial resistance (AMR) profile. This assembly provides a valuable resource for studying the evolution of AMR mechanisms in nontuberculous mycobacteria and offers insight into resistance phenotypes observed in clinical isolates.
- Open Access
- 22 December 2025
- Published by Microbiology Society
- p. 001110.v2
Draft Genome Sequence of a non-tuberculous Mycobacterium Strain Isolated from a Clinical Urine Sample.
Here we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory (SMRL), Royal Infirmary of Edinburgh, UK. The reported genome has a length of 6,749,454 bp, a GC content of 67.2%, and 6,336 protein-coding sequences. Average nucleotide identity (ANI) analysis identified Mycobacterium vanbaalenii PYR-1 as the closest relative (83.32% ANI), indicating that this isolate likely represents a novel species within the genus. Notably, phenotypic characterisation revealed a distinct antimicrobial resistance (AMR) profile. This assembly provides a valuable resource for studying the evolution of antimicrobial resistance mechanisms in nontuberculous mycobacteria and offers insight into resistance phenotypes observed in clinical isolates.
- 22 December 2025
- Published by Microbiology Society
- p. 001110.v2
Open AccessDraft Genome Sequence of a non-tuberculous Mycobacterium Strain Isolated from a Clinical Urine Sample.
Here we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory (SMRL), Royal Infirmary of Edinburgh, UK. The reported genome has a length of 6,749,454 bp, a GC content of 67.2%, and 6,336 protein-coding sequences. Average nucleotide identity (ANI) analysis identified Mycobacterium vanbaalenii PYR-1 as the closest relative (83.32% ANI), indicating that this isolate likely represents a novel species within the genus. Notably, phenotypic characterisation revealed a distinct antimicrobial resistance (AMR) profile. This assembly provides a valuable resource for studying the evolution of antimicrobial resistance mechanisms in nontuberculous mycobacteria and offers insight into resistance phenotypes observed in clinical isolates.
- Open Access
- 3 September 2025
- Published by Microbiology Society
- p. 001110.v1
Draft Genome Sequence of a non-tuberculous Mycobacterium Strain Isolated from a Clinical Urine Sample.
Here we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory (SMRL), Royal Infirmary of Edinburgh, UK. The reported Mycobacterium genome has a length of 6,749,454 bp, a GC content of 67.2%, and 6,336 protein coding sequences. An average nucleotide identity (ANI) analysis found that the closest relative was Mycobacterium vanbaalenii PYR-1, with 83.32% ANI.
- 3 September 2025
- Published by Microbiology Society
- p. 001110.v1
Open AccessDraft Genome Sequence of a non-tuberculous Mycobacterium Strain Isolated from a Clinical Urine Sample.
Here we report the draft sequence of a rapid-growing nontuberculous Mycobacterium isolated from a urine sample at the Scottish Mycobacteria Reference Laboratory (SMRL), Royal Infirmary of Edinburgh, UK. The reported Mycobacterium genome has a length of 6,749,454 bp, a GC content of 67.2%, and 6,336 protein coding sequences. An average nucleotide identity (ANI) analysis found that the closest relative was Mycobacterium vanbaalenii PYR-1, with 83.32% ANI.
- Open Access
- 9 June 2025
- Published by Wiley in Molecular Microbiology
- Vol. 124 (3) , 189-203
Staphylococcus aureus COL: An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase
Methicillin‐resistant Staphylococcus aureus (MRSA) has been a pathogen of global concern since its emergence in the 1960s. As one of the first MRSA strains isolated, COL has become a common model strain of S. aureus. Here we report that COL is, in fact, an atypical strain of MRSA that exhibits slow growth and multidrug tolerance. Genomic analysis identified three mutated genes in COL (rpoB, gltX and prs) with links to tolerance. Allele swapping experiments between COL and the closely‐related, nontolerant Newman strain uncovered a complex interplay between these genes. However, Prs (phosphoribosyl pyrophosphate [PRPP] synthetase) accounted for most of the growth and tolerance phenotype of COL. Biochemical and transcriptomic analysis revealed that COL does not exhibit slow growth as a result of partial stringent response activation, as previously proposed. Instead, the COL Prs mutation greatly reduces the PRPP synthetase activity of the enzyme and leads to downregulation of pyrimidine, histidine, and tryptophan synthesis, three pathways that rely on PRPP. Overall, our findings indicate that COL is an atypical, antibiotic‐tolerant strain of MRSA whose isolation predates the previous first report of tolerance among clinical isolates. Characterization of clinical Prs mutations and their relationship with tolerance requires further investigation.
- 9 June 2025
- Published by Wiley in Molecular Microbiology
- Vol. 124 (3) , 189-203
Open AccessStaphylococcus aureus COL: An Atypical Model Strain of MRSA That Exhibits Slow Growth and Antibiotic Tolerance due to a Mutation in PRPP Synthetase
Methicillin‐resistant Staphylococcus aureus (MRSA) has been a pathogen of global concern since its emergence in the 1960s. As one of the first MRSA strains isolated, COL has become a common model strain of S. aureus. Here we report that COL is, in fact, an atypical strain of MRSA that exhibits slow growth and multidrug tolerance. Genomic analysis identified three mutated genes in COL (rpoB, gltX and prs) with links to tolerance. Allele swapping experiments between COL and the closely‐related, nontolerant Newman strain uncovered a complex interplay between these genes. However, Prs (phosphoribosyl pyrophosphate [PRPP] synthetase) accounted for most of the growth and tolerance phenotype of COL. Biochemical and transcriptomic analysis revealed that COL does not exhibit slow growth as a result of partial stringent response activation, as previously proposed. Instead, the COL Prs mutation greatly reduces the PRPP synthetase activity of the enzyme and leads to downregulation of pyrimidine, histidine, and tryptophan synthesis, three pathways that rely on PRPP. Overall, our findings indicate that COL is an atypical, antibiotic‐tolerant strain of MRSA whose isolation predates the previous first report of tolerance among clinical isolates. Characterization of clinical Prs mutations and their relationship with tolerance requires further investigation.
- Open Access
- 15 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (5) , 507
Surviving Colonies of Pseudomonas aeruginosa Isolated In Vivo from Infected, Antibiotic-Treated Galleria mellonella Larvae Acquire an Antibiotic-Tolerant Phenotype
Background: The aim of this work was to induce the formation of antibiotic-tolerant and/or persister cells in vivo using antibiotic therapy on Galleria mellonella larvae infected with P. aeruginosa, isolate these surviving cells, and characterise their phenotype and genotype. Methods: Infected larvae were treated with effective doses of either ceftazidime or meropenem. Despite this, surviving P. aeruginosa colonies were isolated from living larvae, and antibiotic killing, fitness, virulence, antibiotic resistance and the whole genome sequence of a selection of these isolates were compared with their original parent strains. Results: The surviving isolates had an increased minimum duration to kill 99% of the population (MDK99) upon exposure to ceftazidime or meropenem and decreased growth rates in culture, but they showed no change to the MIC or virulence—consistent with an antibiotic-tolerant phenotype. Long-read genome sequencing of selected isolates revealed only one single nucleotide polymorphism (SNP) within bkdB, encoding the lipoamide acyltransferase component of the branched-chain α-keto acid dehydrogenase, present in two independent isolates. However, time-kill assays with ceftazidime of bkdB knockout strains showed no significant change in the MDK99. Concomitant with the antibiotic-tolerant phenotype, many of the isolates also had a reduced rate of killing when exposed to heat stress. Conclusions: P. aeruginosa cells that survived antibiotic therapy in vivo were found to be antibiotic-tolerant and thermotolerant but not antibiotic-resistant and had reduced growth rates under optimal conditions but unchanged virulence. In the absence of a convincing genetic explanation, the co-induction of enhanced thermotolerance with antibiotic tolerance indicated that both are conferred by a heritable phenotypic mechanism.
- 15 May 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (5) , 507
Open AccessSurviving Colonies of Pseudomonas aeruginosa Isolated In Vivo from Infected, Antibiotic-Treated Galleria mellonella Larvae Acquire an Antibiotic-Tolerant Phenotype
Background: The aim of this work was to induce the formation of antibiotic-tolerant and/or persister cells in vivo using antibiotic therapy on Galleria mellonella larvae infected with P. aeruginosa, isolate these surviving cells, and characterise their phenotype and genotype. Methods: Infected larvae were treated with effective doses of either ceftazidime or meropenem. Despite this, surviving P. aeruginosa colonies were isolated from living larvae, and antibiotic killing, fitness, virulence, antibiotic resistance and the whole genome sequence of a selection of these isolates were compared with their original parent strains. Results: The surviving isolates had an increased minimum duration to kill 99% of the population (MDK99) upon exposure to ceftazidime or meropenem and decreased growth rates in culture, but they showed no change to the MIC or virulence—consistent with an antibiotic-tolerant phenotype. Long-read genome sequencing of selected isolates revealed only one single nucleotide polymorphism (SNP) within bkdB, encoding the lipoamide acyltransferase component of the branched-chain α-keto acid dehydrogenase, present in two independent isolates. However, time-kill assays with ceftazidime of bkdB knockout strains showed no significant change in the MDK99. Concomitant with the antibiotic-tolerant phenotype, many of the isolates also had a reduced rate of killing when exposed to heat stress. Conclusions: P. aeruginosa cells that survived antibiotic therapy in vivo were found to be antibiotic-tolerant and thermotolerant but not antibiotic-resistant and had reduced growth rates under optimal conditions but unchanged virulence. In the absence of a convincing genetic explanation, the co-induction of enhanced thermotolerance with antibiotic tolerance indicated that both are conferred by a heritable phenotypic mechanism.
- Open Access
Staphylococcus aureus COL: An Atypical Model Strain of MRSA that Exhibits Slow Growth and Antibiotic Tolerance Due to a Mutation in PRPP Synthetase
Summary: Methicillin-resistant Staphylococcus aureus (MRSA) has been a pathogen of global concern since its emergence in the 1960s. As one of the first MRSA strains isolated, COL has become a common model strain of S. aureus . Here we report that COL is, in fact, an atypical strain of MRSA that exhibits slow growth and multidrug tolerance. Genomic analysis identified three mutated genes in COL ( rpoB, gltX and prs ) with links to tolerance. Allele swapping experiments between COL and the closely related, non-tolerant Newman strain uncovered a complex interplay between these genes. However, Prs (phosphoribosyl pyrophosphate [PRPP] synthetase) accounted for most of the growth and tolerance phenotype of COL. Biochemical and transcriptomic analysis revealed that COL does not exhibit slow growth as a result of partial stringent response activation, as previously proposed. Instead, the COL Prs mutation greatly reduces the PRPP synthetase activity of the enzyme and leads to downregulation of pyrimidine, histidine and tryptophan synthesis, three pathways that rely on PRPP. Overall, our findings indicate that COL is an atypical, antibiotic-tolerant strain of MRSA whose isolation predates the previous first report of tolerance among clinical isolates. Characterisation of clinical Prs mutations and their relationship with tolerance requires further investigation.
Open AccessStaphylococcus aureus COL: An Atypical Model Strain of MRSA that Exhibits Slow Growth and Antibiotic Tolerance Due to a Mutation in PRPP Synthetase
Summary: Methicillin-resistant Staphylococcus aureus (MRSA) has been a pathogen of global concern since its emergence in the 1960s. As one of the first MRSA strains isolated, COL has become a common model strain of S. aureus . Here we report that COL is, in fact, an atypical strain of MRSA that exhibits slow growth and multidrug tolerance. Genomic analysis identified three mutated genes in COL ( rpoB, gltX and prs ) with links to tolerance. Allele swapping experiments between COL and the closely related, non-tolerant Newman strain uncovered a complex interplay between these genes. However, Prs (phosphoribosyl pyrophosphate [PRPP] synthetase) accounted for most of the growth and tolerance phenotype of COL. Biochemical and transcriptomic analysis revealed that COL does not exhibit slow growth as a result of partial stringent response activation, as previously proposed. Instead, the COL Prs mutation greatly reduces the PRPP synthetase activity of the enzyme and leads to downregulation of pyrimidine, histidine and tryptophan synthesis, three pathways that rely on PRPP. Overall, our findings indicate that COL is an atypical, antibiotic-tolerant strain of MRSA whose isolation predates the previous first report of tolerance among clinical isolates. Characterisation of clinical Prs mutations and their relationship with tolerance requires further investigation.
- Open Access
- 1 August 2024
- Published by Microbiology Society in Access Microbiology
- Vol. 6 (6) , 000710.v3
Unearthing new learning opportunities: adapting and innovating through the ‘Antibiotics under our feet’ citizen science project in Scotland during COVID-19
‘Antibiotics under our feet’ is a Scottish citizen science project that aimed to raise science capital in primary school learners and their teachers through measurement of microbial diversity in urban soil samples in the search for novel antimicrobial compounds. Resistance to antibiotics is rising, posing a global threat to human health. Furthermore, science, technology, engineering and mathematics (STEM) skills are in crisis, jeopardising our capacity to mobilise as a society to fight antimicrobial resistance (AMR). Originally conceived as a response to the AMR and STEM emergencies, our project was hit by the unprecedented challenge of engaging with schools during the COVID-19 pandemic. We describe how we adapted our project to enable remote participation from primary schools and youth groups, utilising COVID-19 response initiatives as opportunities for multi-level co-creation of resources with learners in primary, secondary, and higher education. We produced portable kit boxes for soil sample collection with learning activities and videos linked to the Scottish Curriculum for Excellence. We also addressed glaring project specific content gaps relating to microbiology on English and Simple English Wikipedia. Our hybrid model of working extended our geographical reach and broadened inclusion. We present here the inception, implementation, digital resource outputs, and discussion of pedagogical aspects of ‘Antibiotics under our feet’. Our strategies and insights are applicable post-pandemic for educators to develop STEM skills using soil, microbes, and antibiotics as a theme.
- 1 August 2024
- Published by Microbiology Society in Access Microbiology
- Vol. 6 (6) , 000710.v3
Open AccessUnearthing new learning opportunities: adapting and innovating through the ‘Antibiotics under our feet’ citizen science project in Scotland during COVID-19
‘Antibiotics under our feet’ is a Scottish citizen science project that aimed to raise science capital in primary school learners and their teachers through measurement of microbial diversity in urban soil samples in the search for novel antimicrobial compounds. Resistance to antibiotics is rising, posing a global threat to human health. Furthermore, science, technology, engineering and mathematics (STEM) skills are in crisis, jeopardising our capacity to mobilise as a society to fight antimicrobial resistance (AMR). Originally conceived as a response to the AMR and STEM emergencies, our project was hit by the unprecedented challenge of engaging with schools during the COVID-19 pandemic. We describe how we adapted our project to enable remote participation from primary schools and youth groups, utilising COVID-19 response initiatives as opportunities for multi-level co-creation of resources with learners in primary, secondary, and higher education. We produced portable kit boxes for soil sample collection with learning activities and videos linked to the Scottish Curriculum for Excellence. We also addressed glaring project specific content gaps relating to microbiology on English and Simple English Wikipedia. Our hybrid model of working extended our geographical reach and broadened inclusion. We present here the inception, implementation, digital resource outputs, and discussion of pedagogical aspects of ‘Antibiotics under our feet’. Our strategies and insights are applicable post-pandemic for educators to develop STEM skills using soil, microbes, and antibiotics as a theme.
- Open Access
- 7 March 2024
- Published by Microbiology Society
- p. 000710.v2
Unearthing New Learning Opportunities: Adapting and Innovating through the “Antibiotics Under Our Feet” Citizen Science Project in Scotland during COVID-19
“Antibiotics under our feet” is a Scottish citizen science project that aimed to raise science capital in primary school learners and their teachers through measurement of microbial diversity in urban soil samples in the search for novel antimicrobial compounds. Resistance to antibiotics is rising, posing a global threat to human health. Furthermore, science, technology, engineering and mathematics (STEM) skills are in crisis, jeopardising our capacity to mobilise as a society to fight antimicrobial resistance (AMR). Originally conceived as a response to the AMR and STEM emergencies, our project was hit by the unprecedented challenge of engaging with schools during the COVID-19 pandemic. We describe how we adapted our project to enable remote participation from primary schools and youth groups, utilising COVID-19 response initiatives as opportunities for multi-level co-creation of resources with learners in primary, secondary, and higher education. We produced portable kit boxes for soil sample collection with learning activities and videos linked to the Scottish Curriculum for Excellence. We also addressed glaring project specific content gaps relating to microbiology on English and Simple English Wikipedia. Our hybrid model of working extended our geographical reach and broadened inclusion. We present here the inception, implementation, digital resource outputs, and evaluation of pedagogical aspects of “Antibiotics under our feet”. Our strategies and insights are applicable post-pandemic for educators to develop STEM skills using soil, microbes, and antibiotics as a theme.
- 7 March 2024
- Published by Microbiology Society
- p. 000710.v2
Open AccessUnearthing New Learning Opportunities: Adapting and Innovating through the “Antibiotics Under Our Feet” Citizen Science Project in Scotland during COVID-19
“Antibiotics under our feet” is a Scottish citizen science project that aimed to raise science capital in primary school learners and their teachers through measurement of microbial diversity in urban soil samples in the search for novel antimicrobial compounds. Resistance to antibiotics is rising, posing a global threat to human health. Furthermore, science, technology, engineering and mathematics (STEM) skills are in crisis, jeopardising our capacity to mobilise as a society to fight antimicrobial resistance (AMR). Originally conceived as a response to the AMR and STEM emergencies, our project was hit by the unprecedented challenge of engaging with schools during the COVID-19 pandemic. We describe how we adapted our project to enable remote participation from primary schools and youth groups, utilising COVID-19 response initiatives as opportunities for multi-level co-creation of resources with learners in primary, secondary, and higher education. We produced portable kit boxes for soil sample collection with learning activities and videos linked to the Scottish Curriculum for Excellence. We also addressed glaring project specific content gaps relating to microbiology on English and Simple English Wikipedia. Our hybrid model of working extended our geographical reach and broadened inclusion. We present here the inception, implementation, digital resource outputs, and evaluation of pedagogical aspects of “Antibiotics under our feet”. Our strategies and insights are applicable post-pandemic for educators to develop STEM skills using soil, microbes, and antibiotics as a theme.